Canned
tuna or canned poison? That was the teaser for a CBS 2 News
"HealthWatch" Report of Nov. 22 that focused on high levels
of mercury found in tuna and the possible health risks associated
with them.
CBS 2 News reporter Paul Moniz quoted a number of physicians,
who observed of the toxic substance that, "Once it gets into
our bodies, a substantial part of it will end up in our nervous
system, in our brains, and it's there that it causes a variety
of symptoms." A pediatrician is quoted as saying, "We know
that high levels of mercury can impair the cognitive development
as well as the growth and development of a young child." What
the report appears to be revealing is that while overweight
Americans may flee to fish to lose unwanted pounds, too much
of that tasty tuna could reduce the IQ more than the waistline.
What
the critics of mercury in vaccines find provocative about
this report is the acknowledgement by physicians that the
high levels of mercury ingested from canned tuna can cause
severe health risks. One such critic, the mother of an autistic
child, wonders "why everyone gets up in arms over ingesting
small amounts of mercury from fish or from breaking a thermometer
but finds it acceptable to inject an even more toxic form
of mercury directly into the bloodstream of infants. The evidence
is overwhelming that hundreds of thousands of children were
damaged by gross overexposure to mercury through vaccines
[containing thimerosal] and millions more were and continue
to be put at risk, yet network news has not addressed this
in any significant way. The public needs and deserves to know
the truth - not only about the biggest medical bungling in
our history, but also about the extraordinary efforts of both
the pharmaceutical industry and government agencies to cover
it up."
A pharmaceutical and government cover-up? It is a familiar
enough accusation, and this time the fuse was lit by yet another
study from the federal Centers for Disease Control and Prevention
(CDC), this one titled Safety of Thimerosal-Containing Vaccines:
A Two-Phased Study of Computerized Health Maintenance Organization
Databases. The report concluded that "no consistent significant
associations were found between TCVs [thimerosal-containing
vaccines] and neurodevelopment outcomes." Critics scoff at
such a conclusion. "Sure," laughs one, "they say you can't
eat tuna because the level of mercury you ingest isn't good
for you, but there's no health risk associated with injecting
high levels of mercury directly into a newborn baby?"
The
CDC study, released in the November 2003 issue of Pediatrics,
seemed to puzzle news media, with most who took note of it
making at least a mention of the fact that the lead author,
Thomas Verstraeten, was an employee of GlaxoSmithKline, the
pharmaceutical giant and vaccine manufacturer, when he submitted
the study for publication.
The first part of the two-phase study to determine whether
there is a connection between thimerosal-containing vaccines
and neurodevelopment disorders began in 1999 and involved
the review of data from Seattle's Group Health Cooperative
and Northern California Kaiser, both large health-maintenance
organizations (HMOs). The data used in this first phase actually
revealed a significant association between TCVs administered
to infants and later developmental abnormalities such as speech
and language delays and neurodevelopment problems in general,
such as tics and the alleged hyperactivity symptoms of attention-deficit
disorder and attention-deficit/hyperactivity disorder.
However, this conclusion was not included in the final draft;
it was only made public afterward when Verstraeten's notes
were revealed in another forum, according to specialists.
The notes, not published with the CDC study, showed that the
"relative risk" for autism was 2.48 times higher for children
who received 62.5 micrograms or more of mercury from TCVs
by 3 months of age.
The second phase of the study in June 2000, however, involved
the Harvard Pilgrim HMO in Massachusetts - an unlikely choice,
critics say. Among the problems with using Harvard Pilgrim's
database was that the HMO was in bankruptcy and had been taken
over by the commonwealth of Massachusetts. The medical records
not only were incomplete, but the data were stored with a
diagnostic coding system completely unlike that used in the
first phase of the study using data from the two West Coast
HMOs. Furthermore, the Harvard Pilgrim data, say the expert
analysts, had incomplete data on autism and did not even address
the issue.
Thus medical reviewers of the CDC study charge that it is
rife with data manipulation. Since it relied on incompatible
diagnostic coding to validate whether there were adverse effects
from exposure to TCVs, the effect was to sabotage the result.
So, they say, it was not surprising that the CDC study's analysis
of the Harvard Pilgrim data found no consistent association
between vaccines containing thimerosal and the mercury-related
neurological disorders found previously in the first phase
based on the two West Coast HMOs.
One of the few physicians in Congress, Rep. Dave Weldon (R-Fla.),
immediately saw the problems associated with the CDC study
and notified CDC Director Julie Gerberding. Weldon wrote,
"I have serious reservations about the four-year evolution
and conclusions of this study. A review of these documents
leaves me very concerned that rather than seeking to understand
whether or not some children were exposed to harmful levels
of mercury in childhood vaccines in the 1990s, there may have
been a selective use of the data to make the associations
in the earliest study disappear."
Weldon's letter to Gerberding goes on to observe that "the
first version of the study, produced in February 2000, found
a significant association between exposure to thimerosal-containing
vaccines and autism and neurological developmental delays.
A June 2000 version of the study applied various data manipulations
to reduce the autism association to 1.69, and the authors
went outside the VSD [Vaccine Safety Datalink] database to
secure data from a Massachusetts HMO [Harvard Pilgrim] in
order to counter the association found between TCVs and speech
delays." Clear enough.
The Florida lawmaker, who is a staunch supporter of immunization,
tells Insight, "I don't know what's going on. It's a pretty
lame study to begin with. The way they've done it is they
got some findings and started adding more numbers to the denominator
- it's kind of a strange protocol they followed. Then there
are all these quotes from the researchers from other documents
about how you can add numbers and stratify things and get
any outcome you want. Then you consider that the lead author
is working for a drug company, didn't disclose this fact and
also that it is one of the drug companies being sued over
this mercury issue. I'm just very concerned that we're not
going to get answers as long as there are careers at stake.
You know there are people at the CDC who have been involved
in the vaccine program who didn't recognize the amount of
mercury they were giving kids, and now they're in the process
of investigating themselves. Meanwhile a lot of these investigators
bounce to and from the drug companies. I think it all is very,
very murky and very suspicious."
Weldon summarizes: "The CDC produced an article by Dr. Verstraeten,
published on Nov. 3 in Pediatrics. Dr. Verstraeten is a former
CDC employee. Since 2001 he has worked for GlaxoSmithKline
- a vaccine manufacturer. While working for the CDC in 2000,
the first version of Dr. Verstraeten's unpublished study found
an association between higher thimerosal exposures and neurodevelopment
disorders, including autism. Between 2000 and 2003, Dr. Verstraeten
and coauthors manipulated and stratified the data so much
that each of these associations magically disappeared. I don't
know if it was deliberate, but that is nonetheless what happened.
This study has done nothing in my mind to put these concerns
to rest, but only serves to raise suspicions."
This veteran member of Congress puts it plainly: "We're not
going to get answers to these questions until Congress or
some outside group starts poring through this information.
But it's very coincidental that they added the hepatitis vaccine,
the HiB vaccine and the chicken-pox vaccine - they added all
these additional childhood vaccines around the time when the
autism rate started to skyrocket. Then when you actually sit
down and do the calculations, according to the Environmental
Protection Agency [EPA], they were giving these kids very
toxic levels of mercury. I mean as a 150- to 200-pound adult
the EPA says you're not supposed to take in more than one
microgram per day. They were taking little seven- and 10-pound
babies and pumping 50 and 75 micrograms of mercury into them
in one shot. That's like giving an adult 1,000 micrograms.
And, on top of that, the World Health Organization says mercury
is 10 times more toxic in children than it is in adults. It's
horrifying."
While Weldon and others cite huge and undeniable flaws, a
spokesman for the CDC, Von Roebuck, tells Insight that "the
CDC stands by the study." As he explains it, "We pretty much
looked into that [manipulation of data] in the sense of how
the information was presented, and we do stand behind it.
The CDC knew that Dr. Verstraeten worked for GlaxoSmithKline,
and the one thing that we would want to happen differently
is that would have been known before, but the work that Dr.
Verstraeten did was for the CDC at the time the work was produced
- the work that he did for the study was done when he worked
for the CDC."
Mark Geier, M.D., Ph.D., is president of the Genetic Centers
of America. He and his son, David Geier, president of Medcon
Inc., are consultants on vaccine cases. David Geier tells
Insight, "What happened here is Dr. Verstraeten goes to the
Institute of Medicine [IOM] and says that he looked at it
in one California HMO and it was statistical and he saw the
effect, and then he did it in another California HMO and it
was statistical and he saw the effect, then he went to Harvard
Pilgrim HMO and he didn't see the effect. The IOM said it's
biologically plausible, but the epidemiology is mixed and
therefore we're not sure."
"In my opinion," explains Mark Geier, "if they had seen clear
epidemiology they would have recommended the immediate removal
of thimerosal and hundreds of children would have been saved.
But Verstraeten went to the one state in the country where
the percentage of autism was the lowest. According to the
U.S. Department of Education the average increase in autism
was 400 percent, and every state in the union had at least
a 100 percent increase. But Harvard Pilgrim had just a 10
percent increase."
"We went to Atlanta," he continues, "to the CDC, and looked
at the VSD data. There is thimerosal-containing DTaP [diphtheria,
tetanus and pertussis vaccine] and thimerosal-free DTaP, so
we asked a question: Among children that got a minimum of
either three consecutive thimerosal-containing DTaPs or three
consecutive thimerosal-free DTaPs, was there a difference
in the number of autism cases in the two groups? We found
mega differences. More than 20 times higher. The rate of autism
in the children that got more than three doses of thimerosal-containing
DTaP vaccines was much, much higher. Almost all the children
that have autism in that group were the ones that got the
thimerosal-containing DTaP vaccine. The more thimerosal the
greater the cases of autism."
Mark Geier says, "Believe us, there is no scientific issue
here. This is fraud. The CDC and the FDA [Food and Drug Administration]
know what is happening. They just can't admit it because it
is one of the worst things ever to have happened to this United
States. If a terrorist had done this, we wouldn't attack them,
we'd nuke them. We're talking about one in eight children
in the U.S. that currently are in special education, and that
number is going to change to about one in five. What percentage
of our young population can we destroy before we realize how
serious this is?"
Lyn Redwood, a registered nurse, mother of an autistic child
and president and cofounder of http://www.safeminds.org/
(Sensible Action for Ending Mercury-Induced Neurological Disorders),
a nonprofit organization dedicated to ending devastation caused
by the needless use of mercury in medicines, tells Insight
that "there are so many problems with the study, but over
time you can see how all the manipulations of the data slowly
bring down the signals for neurological disorders. I think
they were trying to get lower numbers. It must be very hard
to admit that a program that was designed to eradicate infectious
disease has resulted in an epidemic of a whole new kind of
disease. But to think that we weren't given a choice when
the regulators and manufacturers knew these products contained
mercury is inconceivable."
Redwood says with a sigh, "On a scale of one to 10, I give
the CDC study a big fat zero. I think it started out good,
but when they saw the early numbers it scared the hell out
of them. I don't have any faith in the CDC doing a decent
study of this matter. It's like having the tobacco industry
monitor cigarettes for safety. From a parent's perspective
and from a health-care professional's perspective it's maddening
that we can't get products that are safe, and yet we're forced
by law to use them. They need to just get the thimerosal out.
It's barbaric."
Kelly Patricia O'Meara is an investigative reporter for
Insight.
email the
author
